Search results for: 'drug editing b'

The drug approvals of Yescarta (axicabtagene ciloleucel), Luxturna (Voretigene neparvovec) and Kymriah (Tisagenlecleucel) have turned a leaf in the pharmaceutical chapter of gene therapy development. Currently, genetic disorders do not have satisfactory treatment outcomes. This is in part due to the inability of small molecule drugs and enzyme repl...

Organ-on-a-chip technology involves the incorporation of microphysiological systems harboring dynamic living 3D organoids, tissue-culture, or cell cultures on a microfluidic platform. The physiologically relevant Organ-chip models offer a better and more precise insight to the possible in vivo effects of drugs in the human body. The flexibility of ...

This research service encompasses a comprehensive analysis of RNA therapy industry from the following perspectives: • Industry Drivers and Challenges • Technology Snapshot and Trends • Clinical Pipeline Analysis • Overview of the IP Landscape • Innovator Profiles • Future Roadmap The RNA therapy platforms covered include: • Splice-Switching Oligon...

Over the past several decades drug therapies for clinically safe and effective management of various types of pain, classified as being acute, chronic, breakthrough, nerve, and bone-related have been treated with the use of opioids, NSAIDS, anticonvulsants and antidepressants. However, increasing reliance on their use for prolonged intervals and si...

15 Mar 2018  |  North America  |  Market Outlook

Global Autonomous Driving Market Outlook, 2018

The Global Autonomous Driving Market is Expected Grow up to $173.15 B by 2030, with Shared Mobility Services Contributing to 65.31%

Infographics

×

2018 will see the first true deployment of automation where the vehicle will tell the driver with the first level 3 (L3) autonomous capability by taking the driver out of the loop to be introduced next year. Ironically, this may happen through a software patch update or a flagship generational product launch. Regardless of the medium through which ...

19 Jan 2018  |  North America  |  Market Research

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

The Next Generation of Cancer Therapies

Infographics

×

Key Issues Addressed

Immuno-oncology refers to drugs that are used to stimulate the human immune system to target the fight against cancer. The immune system is capable of recognizing and eliminating foreign substances, including tumor cells. Tumors have, however, been able to escape detection by the immune system. There are drugs that can empower the immune system cel...

04 Dec 2018  |  North America  |  Market Research

Food & Beverages 4.0, 2018

IIoT for the Food & Beverages Industry

Infographics

×

The Future of Food & Beverage (F&B) Manufacturing with IIoT. The impact of information technology (IT) on the manufacturing industry has been tremendous in recent times. With an increasing number of machines being connected to the Internet, data is being generated in huge volumes. Advancements in real-time data processing and predictive analytics...

This research service encompasses microbiome technology trends and emerging innovations across: Disease Management This research segment explores the emerging role of microbiome-based therapeutics across a wide range of diseases, especially in the context of gastro-intestinal health, while providing strategic insights across the highly dynamic com...

The Internet of Things (IoT) and traceability for food and beverage (F&B) manufacturing market was valued at $4.08 billion in market revenue in 2017 and is expected to reach $8.43 billion by 2025, growing at a compound annual growth rate (CAGR) of 9.5%. Supply chain traceability is the information system that is required to track the history of a p...